152567-81-2 Usage
Uses
Used in Pharmaceutical Industry:
2-(3-Fluoro-4-methoxybenzoyl)benzoic acid is used as a synthetic intermediate for the development of new pharmaceutical compounds. Its unique structure allows for the creation of diverse organic molecules with potential therapeutic applications.
Used in Medicinal Chemistry Research:
In the realm of medicinal chemistry, 2-(3-Fluoro-4-methoxybenzoyl)benzoic acid serves as a valuable research tool. It is employed in the exploration of new chemical entities and the optimization of drug candidates, leveraging its anti-inflammatory and antioxidant properties for potential therapeutic benefits.
Used in Organic Synthesis:
2-(3-Fluoro-4-methoxybenzoyl)benzoic acid is utilized as a building block in organic synthesis, enabling the construction of complex organic molecules with specific biological activities. Its versatility in chemical reactions contributes to the advancement of organic chemistry and the discovery of novel compounds with potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 152567-81-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,2,5,6 and 7 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 152567-81:
(8*1)+(7*5)+(6*2)+(5*5)+(4*6)+(3*7)+(2*8)+(1*1)=142
142 % 10 = 2
So 152567-81-2 is a valid CAS Registry Number.
152567-81-2Relevant articles and documents
Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. 1. 2-[2-(1-imidazolyl)alkyl]- 1(2H)-phthalazinones
Yamaguchi,Kamei,Koga,Akima,Kuroki,Ohi
, p. 4052 - 4060 (2007/10/02)
A number of 4-substituted 2-[ω-(1-imidazolyl)alkyl]-1(2H)-phthalazinones were synthesized in order to develop agents possessing both thromboxane A2 synthetase inhibitory and bronchodilatory activities. The pharmacological evaluation of these compounds disclosed that they have both activities to various extents. Both activities were slightly dependent on the length of the 2-substituents and largely affected by the nature of the 4-substituents. Compounds bearing phenyl and thienyl groups exhibited relatively high and well-rounded activities. Among these compounds, 12j and 15f were found to be the most effective agents having well-rounded activities in vitro and in vivo. Introduction of a carboxyl group reduced both activities contrary to our expectation. 4-(3-Pyridyl)phthalazinone 18b was of particular interest because of unexpectedly high in vivo activities in spite of an absence of significant in vitro activities.
